Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Mbio
|
September 8, 2016
A Putative Bacterial ABC Transporter Circumvents the Essentiality of Signal Peptidase
J Hiroshi Morisaki, Peter A Smith, Shailesh V Date, et al.
The Journal of Biological Chemistry
|
June 14, 2000
Characterization of the human cysteinyl leukotriene 2 receptor
C E Heise, B F O'Dowd, D J Figueroa, et al.
ACS Medicinal Chemistry Letters
|
December 30, 2015
Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety
Chudi O Ndubaku, James J Crawford, Joy Drobnick, et al.
Nature
|
September 14, 2018
Optimized arylomycins are a new class of Gram-negative antibiotics
Peter A Smith, Michael F T Koehler, Hany S Girgis, et al.
Journal of Medicinal Chemistry
|
May 12, 2016
Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window
Joachim Rudolph, Lesley J Murray, Chudi O Ndubaku, et al.
Nature Communications
|
October 8, 2024
The discovery and structural basis of two distinct state-dependent inhibitors of BamA
Dawei Sun, Kelly M Storek, Dimitry Tegunov, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Mbio
|
September 8, 2016
A Putative Bacterial ABC Transporter Circumvents the Essentiality of Signal Peptidase
J Hiroshi Morisaki, Peter A Smith, Shailesh V Date, et al.
The Journal of Biological Chemistry
|
June 14, 2000
Characterization of the human cysteinyl leukotriene 2 receptor
C E Heise, B F O'Dowd, D J Figueroa, et al.
ACS Medicinal Chemistry Letters
|
December 30, 2015
Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety
Chudi O Ndubaku, James J Crawford, Joy Drobnick, et al.
Nature
|
September 14, 2018
Optimized arylomycins are a new class of Gram-negative antibiotics
Peter A Smith, Michael F T Koehler, Hany S Girgis, et al.
Journal of Medicinal Chemistry
|
May 12, 2016
Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window
Joachim Rudolph, Lesley J Murray, Chudi O Ndubaku, et al.
Nature Communications
|
October 8, 2024
The discovery and structural basis of two distinct state-dependent inhibitors of BamA
Dawei Sun, Kelly M Storek, Dimitry Tegunov, et al.
Page
of 8